Glen Tullman — CEO of care navigation company Transcarent, as well as former CEO of Allscripts and Livongo — discussed what he thinks the future of healthcare will look like during the HIMSS conference in Chicago. He laid out five predictions, including an increased focus on consumer expectations and more investment in AI.
There are currently 97 global digital health companies that are considered unicorns. But getting caught up with the idea of digital health unicorns isn’t very sustainable, according to Emilly Melton, managing partner at Threshold Ventures. Instead of focusing too much on their valuations, she recommended that startups simply focus on getting the capital they need in order to reach the next stage of inflection.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Surgery management has emerged as a key area where employers are collaborating with providers through companies like Transcarent to provide more informed guidance on surgery care delivery options for the best patient outcomes and experience.
A battle of ideas from two prominent health tech CEOs came to life at the recently-concluded HLTH conference in Boston. It's a substantive debate on solving healthcare's entrenched problems and one worth having.
Glen Tullman’s newest healthcare navigation startup, Transcarent, raised another $58 million in funding. The company plans to use the funds to quickly build out its offering for employers.
7wireVentures, the venture capital firm that backed Livongo and other healthcare technology companies, raised $150 million for a new connected consumer fund. It’s already made two investments in patient navigation startups.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Livongo Founder Glen Tullman is leading a new healthcare venture. Called Transcarent, the patient navigation platform strikes risk-sharing agreements with employers.
Throughout this public health crisis, we have faced immense challenges and unimaginably sad losses, but we must either learn lessons from it or risk wasting the sacrifices we’ve made.
Covid-19 has taken a particularly heavy toll on people with chronic conditions. We must make it easier for people to stay healthy at home by providing them with the information, supplies, and support they need delivered when and where they need it.
The chronic disease management company filed its S-1 paperwork on Friday, joining Change Healthcare, Phreesia and Health Catalyst as part of the raft of companies planning to go public after a nearly three year IPO drought in digital health.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
The company, which will be listed on the Nasdaq exchange under the ticker symbol "LVGO," offers tech-enabled solutions that help to monitor and manage people with chronic conditions like diabetes, hypertension and behavioral health issues.
The Wall Street Journal reports that Mountain View, California-based Livongo has enlisted Morgan Stanley, Goldman Sachs Group Inc. and JPMorgan Chase & Co. as underwriters for an IPO that would value the company in excess of $1 billion.
Burke joined the Mountain View, California-based chronic disease management company late last year after spending more than two decades at EHR giant Cerner.
The myStrength news comes fresh off the heels of competitor Omada Health's effort to add on similar services using technology developed by failed behavioral health startup Lantern.
New CFO Lee Shapiro has worked with Livongo Founder Glen Tullman for two decades, both at Allscripts and venture investing firm 7wire Ventures.